Abstract
Background Households (HH) have been traditionally described as the main environments where people are at risk of dengue (and other arbovirus) infection. Mounting entomological evidence has suggested a larger role of environments other than HH in transmission. Recently, an agent-based model (ABM) estimated that over half of infections occur in non-household (NH) environments like workplaces, markets, and recreational sites. However, the importance of human and vector mobility and the configurations of urban spaces in mediating the effects of NH on dengue transmission remains understudied.
Methods To improve our knowledge of the relevance of NH in transmission, we expanded an ABM calibrated from field data in Kenya to examine movement of people and vectors under different spatial configurations of buildings. In this model, we assessed the number of people traveling between HH and NH and their distance. Those were studied on three different urban configurations, on which the NH are spatially distributed either randomly (scattered), centered (in a single center), or clustered (in more than one cluster).
Results Across simulations, the number of people moving is a major influential variable where higher levels of movement between HH and NH increases the number of cases. In addition, the number of cases is higher when NH are scattered. Intriguingly, the distance that people travel from HH to NH seems to have little effect on dengue burden; however, it affects the level of spatial clustering of cases.
Conclusions These results highlight the importance of NH as a major spreader of infections between HH and NH environments supporting the relevance of NH in transmission and its interaction with human movement in driving dengue dynamics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by NIH through the grant R01AI102918 (PI LaBeaud). In addition, V.H.P.G. is supported by grants R01AI102918 and R35GM133439; E.A.M. is supported by NIH grants R35GM133439, R01AI102918, and R01AI168097, and NSF grant DEB-2011147 (with Fogarty International Center); A.D.L. is supported by grants R01AI102918, R01AI149614, R01AI155959, D43TW011547.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
An author was added who by mistake was overlooked in the previous version. The clarity of the methods and calibration of the model is clearer in this version. General improvement of the paper.
Data Availability
All data produced are available online at github.com/vhpenagarcia/ABM_dengue
